이식 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2025-2034년)
Transplantation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
상품코드:1930044
리서치사:Fortune Business Insights Pvt. Ltd.
발행일:2025년 12월
페이지 정보:영문 161 Pages
라이선스 & 가격 (부가세 별도)
한글목차
이식 시장 성장요인
세계 이식 시장은 신장, 간, 심장, 폐, 각막, 피부, 뼈, 힘줄 등의 장기 및 조직 이식과 관련된 의료 시술 및 제품으로 구성되어 있습니다. 이식은 만성질환, 외상, 중독, 혈액 손실, 백혈병, 패혈증, 기타 급성 질환으로 인한 장기 부전으로 고통받는 생명을 구하는 데 매우 중요한 역할을 합니다. 이식 수술에 대한 수요 증가와 더불어 인식 개선과 기술 혁신이 결합하여 시장 성장을 크게 견인하고 있습니다.
시장 규모 및 예측
포춘 비즈니스 인사이트에 따르면, 2025년 세계 이식 시장 규모는 119억 3,000만 달러로 평가됐습니다. 2026년에는 130억 1,000만 달러로 성장하여 2034년까지 285억 7,000만 달러로 확대될 것으로 예상되며, 예측 기간(2026-2034) 동안 10.33%의 CAGR을 기록할 것으로 예상됩니다.
북미는 2025년 42.29%의 점유율로 시장을 선도하고 있으며, 선진화된 의료 인프라, 유리한 상환 정책, 다수의 장기 기증 프로그램 등이 이를 뒷받침하고 있습니다. 또한, 미국 이식 시장은 장기 기증률 증가와 기술 발전에 힘입어 2032년까지 85억 4,000만 달러에 달할 것으로 예상됩니다.
시장 촉진요인
시장 성장을 이끄는 주요 요인은 전 세계 이식 수술 수요의 증가입니다. 암, 신부전, 만성폐쇄성폐질환(COPD), 루푸스 등 만성질환의 유병률 증가로 장기부전 사례가 크게 증가하고 있습니다.
예를 들어, 미국 보건자원서비스국(HRSA)에 따르면, 2024년 2월 기준 미국 전국 장기 이식 대기자 명단에는 10만 3,000명 이상이 등록되어 있습니다. 또한, 2023년에는 미국에서 4만 6,000건 이상의 장기 이식 수술이 시행될 것으로 예상되며, 이는 수술에 대한 강력한 수요를 보여줍니다.
또한, 장기 기증에 대한 인식을 높이기 위한 정부 및 비정부 차원의 노력이 시장 확대를 촉진하고 있습니다. ORGAN India와 영국 국민보건서비스(NHS)와 같은 조직은 기증자 등록을 장려하는 캠페인을 적극적으로 전개하고 있으며, 이를 통해 이식률을 향상시키고 있습니다.
COVID-19의 영향
COVID-19 팬데믹은 특히 2020년에 선택적 수술 감소, 엄격한 안전 지침, 병원 방문 감소로 인해 이식 시장에 부정적인 영향을 미쳤습니다. 전 세계적으로 이식 수술이 감소함에 따라 주요 시장 기업의 매출에도 영향을 미쳤습니다.
그러나 2022년 말까지 병원 운영이 재개되고 장기 기증에 대한 인식이 높아짐에 따라 시장은 점차 회복세를 보이고 있습니다. 전략적 연구 이니셔티브와 신제품 출시로 인해 2024년까지 시장은 팬데믹 이전 성장 궤도로 돌아와 2025년부터 2032년까지 안정적인 성장세를 유지할 수 있을 것으로 예상됩니다.
시장 동향
이식 시장을 형성하는 주요 트렌드 중 하나는 공공 및 민간 이해관계자 간의 협력 강화입니다. 이러한 협력은 장기 기증률 향상, 이식 인프라 강화, 기증자와 수혜자 매칭 과정의 효율화를 목표로 하고 있습니다.
예를 들어, 이식치료 컨소시엄(TTC)은 업계 관계자, 학계, 규제 당국과 협력하여 이식 관련 혁신을 가속화하고 있습니다. 마찬가지로, PAHO(Pan American Health Organization, 범미보건기구)와 스페인 정부와 같은 조직이 참여하는 국제적인 협력을 통해 지역을 넘어선 이식 생태계가 강화되고 있습니다.
성장 요인
또 다른 중요한 성장 요인은 조직공학 및 보존기술의 발전입니다. 3D 바이오프린팅, 줄기세포를 이용한 조직 재생, 이종이식 등의 혁신 기술이 기증자 부족 해소와 거부반응 위험 감소에 기여하고 있습니다.
예를 들어, 2023년 6월 3D BioFibR은 조직 및 장기 바이오프린팅을 위한 새로운 콜라겐 기반 바이오 잉크 제품을 발표했습니다. 이러한 기술 발전은 치료의 가능성을 넓히고 장기적인 시장 성장을 뒷받침하고 있습니다.
억제요인
견조한 성장 전망에도 불구하고 이식 수술 대기 기간이 길어지고 있는 것이 시장의 과제입니다. Donate Life America에 따르면, 미국에서는 8분마다 1명이 이식 대기자 명단에 추가되고 있으며, 신장 이식 대기 기간은 평균 3-5년에 달합니다.
개발도상국에서는 낮은 인지도, 불충분한 보험 상환 제도, 이식 인프라 부족이 시장 성장을 더욱 제한하고 있습니다. 이러한 요인들은 여전히 보급의 장벽으로 작용하고 있습니다.
부문 분석
제품 유형별: 면역억제제 부문은 장기 거부반응 예방에 필수적인 역할을 하는 면역억제제 부문이 2026년 43.18%의 점유율로 시장을 장악할 것으로 예상됩니다.
용도별: 2026년 조직 이식 부문이 63.88%의 시장 점유율을 차지했습니다. 이는 각막이식, 피부이식 등 높은 수술 건수에 힘입은 결과입니다.
최종사용자별: 2026년 병원이 60.06%의 점유율로 시장을 주도했습니다. 이는 병원이 복잡한 이식 수술의 주요 수행 거점으로 자리매김하고 있기 때문입니다.
지역별 인사이트
북미는 2025년 50억 4,000만 달러를 차지할 것으로 예상되며, 첨단 기술과 강력한 규제 지원으로 인해 북미가 계속해서 선두를 달리고 있습니다. 유럽은 인식 개선 활동과 수술 건수 증가에 힘입어 2위 점유율을 유지하고 있습니다. 아시아태평양, 특히 중국, 일본, 인도에서 만성질환 유병률 증가와 의료 인프라 개선으로 인해 빠른 성장을 보이고 있습니다.
The global transplantation market comprises medical procedures and products related to the transplantation of organs and tissues, including kidneys, liver, heart, lungs, cornea, skin, bones, and tendons. Transplantation plays a critical role in saving lives affected by organ failure caused by chronic diseases, trauma, poisoning, blood loss, leukemia, sepsis, and other acute conditions. Rising demand for transplant procedures, coupled with increasing awareness and technological innovation, is significantly driving the market's growth.
Market Size and Forecast
According to Fortune Business Insights, the global transplantation market was valued at USD 11.93 billion in 2025. It is projected to grow to USD 13.01 billion in 2026 and further expand to USD 28.57 billion by 2034, registering a CAGR of 10.33% during the forecast period (2026-2034).
North America dominated the market with a 42.29% share in 2025, supported by advanced healthcare infrastructure, favorable reimbursement policies, and a high number of organ donation programs. Additionally, the U.S. transplantation market is projected to reach USD 8.54 billion by 2032, driven by increasing organ donation rates and technological advancements.
Market Drivers
A key factor driving market growth is the increasing demand for transplantation procedures worldwide. The rising prevalence of chronic conditions such as cancer, kidney failure, chronic obstructive pulmonary disease (COPD), and lupus has significantly increased organ failure cases.
For instance, according to the U.S. Health Resources & Services Administration, over 103,000 individuals were on the U.S. national organ transplant waiting list in February 2024. Furthermore, in 2023, more than 46,000 organ transplant procedures were performed in the U.S., highlighting strong procedural demand.
In addition, government and non-government initiatives promoting organ donation awareness are boosting market expansion. Organizations such as ORGAN India and the National Health Service (NHS) in the U.K. actively run campaigns encouraging donor registration, thereby increasing transplantation rates.
COVID-19 Impact
The COVID-19 pandemic negatively impacted the transplantation market, particularly during 2020, due to reduced elective procedures, strict safety guidelines, and fewer hospital visits. Transplant procedures declined globally, affecting the sales of key market players.
However, the market gradually recovered by the end of 2022, as hospital operations resumed and awareness regarding organ donation increased. Strategic research initiatives and new product launches helped the market return to its pre-pandemic growth trajectory by 2024, supporting stable growth during 2025-2032.
Market Trends
One of the major trends shaping the transplantation market is the increase in collaborations between public and private stakeholders. These collaborations aim to improve organ donation rates, enhance transplant infrastructure, and streamline donor-recipient matching processes.
For example, the Transplant Therapeutics Consortium (TTC) collaborates with industry players, academic institutions, and regulatory agencies to accelerate transplant-related innovations. Similarly, international collaborations involving organizations such as PAHO and the Government of Spain are strengthening transplant ecosystems across regions.
Growth Factors
Another significant growth driver is the advancement in tissue engineering and preservation technologies. Innovations such as 3D bioprinting, stem cell-based tissue regeneration, and xenotransplantation are addressing donor shortages and reducing rejection risks.
For instance, in June 2023, 3D BioFibR launched novel collagen-based bio-ink products for tissue and organ bioprinting. These technological advancements are expanding treatment possibilities and supporting long-term market growth.
Restraining Factors
Despite strong growth prospects, the market faces challenges due to prolonged waiting periods for transplant procedures. According to Donate Life America, one person is added to the U.S. transplant waiting list every 8 minutes, and the average waiting time for kidney transplantation ranges from 3 to 5 years.
In developing countries, limited awareness, inadequate reimbursement policies, and insufficient transplant infrastructure further restrict market growth. These factors continue to act as barriers to widespread adoption.
Segmentation Analysis
By Product Type: The immunosuppressive drugs segment dominated the market with a 43.18% share in 2026, owing to their essential role in preventing organ rejection.
By Application: The tissue transplantation segment held a 63.88% market share in 2026, driven by the high volume of procedures such as corneal and skin transplants.
By End-user: Hospitals led the market with a 60.06% share in 2026, as they remain primary centers for complex transplant procedures.
Regional Insights
North America accounted for USD 5.04 billion in 2025 and continues to dominate due to advanced technologies and strong regulatory support. Europe holds the second-largest share, supported by awareness initiatives and increasing procedures. Asia Pacific is witnessing rapid growth due to rising chronic disease prevalence and improving healthcare infrastructure, particularly in China, Japan, and India.
Competitive Landscape
The market is moderately fragmented, with leading players such as Zimmer Biomet, Astellas Pharma, BioLife Solutions, Novartis AG, TransMedics, and Roche. These companies focus on product innovation, strategic partnerships, and acquisitions to strengthen their market position.
Conclusion
In conclusion, the global transplantation market is expected to grow from USD 11.93 billion in 2025 to USD 28.57 billion by 2034, driven by rising organ failure cases, increasing transplant procedures, supportive government initiatives, and continuous technological advancements. While challenges such as donor shortages and long waiting periods persist, expanding awareness programs, innovation in tissue engineering, and strong collaboration among stakeholders are expected to sustain robust market growth throughout the forecast period.
Segmentation By Product Type
Tissue Products
Immunosuppressive Drugs
Preservation Solutions
By Application
Organ Transplantation
Tissue Transplantation
By End-user
Hospitals
Transplantation Centers
Others
By Region
North America (By Product Type, Application, End-user, and Country/Sub-Region)
U.S. (By Application)
Canada (By Application)
Europe (By Product Type, Application, End-user, and Country/Sub-Region)
Germany (By Application)
France (By Application)
U.K. (By Application)
Italy (By Application)
Spain (By Application)
Scandinavia (By Application)
Rest of Europe (By Application)
Asia Pacific (By Product Type, Application, End-user, and Country/Sub-Region)
China (By Application)
Japan (By Application)
India (By Application)
Australia (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America (By Product Type, Application, End-user, and Country/Sub-Region)
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-Region)
GCC (By Application)
South Africa (By Application)
Rest of the Middle East & Africa (By Application)
Table of Content
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Number of Major Organ Transplantation, By Key Countries, 2025
4.2. Key Industry Developments- Mergers, Acquisitions and Partnerships
4.3. Overview of Regulatory Scenario
4.4. Impact of COVID-19 on the Market
5. Global Transplantation Market Analysis, Insights and Forecast, 2021-2034
5.1. Market Analysis, Insights and Forecast - By Product Type
5.1.1. Tissue Products
5.1.2. Immunosuppressive Drugs
5.1.3. Preservation Solutions
5.2. Market Analysis, Insights and Forecast - By Application
5.2.1. Organ Transplantation
5.2.2. Tissue Transplantation
5.3. Market Analysis, Insights and Forecast - By End User
5.3.1. Hospitals
5.3.2. Transplantation Centers
5.3.3. Others
5.4. Market Analysis, Insights and Forecast - By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Transplantation Market Analysis, Insights and Forecast, 2021-2034
6.1. Market Analysis, Insights and Forecast - By Product Type
6.1.1. Tissue Products
6.1.2. Immunosuppressive Drugs
6.1.3. Preservation Solutions
6.2. Market Analysis, Insights and Forecast - By Application
6.2.1. Organ Transplantation
6.2.2. Tissue Transplantation
6.3. Market Analysis, Insights and Forecast - By End User
6.3.1. Hospitals
6.3.2. Transplantation Centers
6.3.3. Others
6.4. Market Analysis, Insights and Forecast - By Country
6.4.1. U.S.
6.4.1.1. By Application
6.4.2. Canada
6.4.2.1. By Application
7. Europe Transplantation Market Analysis, Insights and Forecast, 2021-2034
7.1. Market Analysis, Insights and Forecast - By Product Type
7.1.1. Tissue Products
7.1.2. Immunosuppressive Drugs
7.1.3. Preservation Solutions
7.2. Market Analysis, Insights and Forecast - By Application
7.2.1. Organ Transplantation
7.2.2. Tissue Transplantation
7.3. Market Analysis, Insights and Forecast - By End User
7.3.1. Hospitals
7.3.2. Transplantation Centers
7.3.3. Others
7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
7.4.1. Germany
7.4.1.1. By Application
7.4.2. France
7.4.2.1. By Application
7.4.3. U.K.
7.4.3.1. By Application
7.4.4. Italy
7.4.4.1. By Application
7.4.5. Spain
7.4.5.1. By Application
7.4.6. Scandinavia
7.4.6.1. By Application
7.4.7. Rest of Europe
7.4.7.1. By Application
8. Asia Pacific Transplantation Market Analysis, Insights and Forecast, 2021-2034
8.1. Market Analysis, Insights and Forecast - By Product Type
8.1.1. Tissue Products
8.1.2. Immunosuppressive Drugs
8.1.3. Preservation Solutions
8.2. Market Analysis, Insights and Forecast - By Application
8.2.1. Organ Transplantation
8.2.2. Tissue Transplantation
8.3. Market Analysis, Insights and Forecast - By End User
8.3.1. Hospitals
8.3.2. Transplantation Centers
8.3.3. Others
8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
8.4.1. China
8.4.1.1. By Application
8.4.2. Japan
8.4.2.1. By Application
8.4.3. India
8.4.3.1. By Application
8.4.4. Australia
8.4.4.1. By Application
8.4.5. Southeast Asia
8.4.5.1. By Application
8.4.6. Rest of Asia Pacific
8.4.6.1. By Application
9. Latin America Transplantation Market Analysis, Insights and Forecast, 2021-2034
9.1. Market Analysis, Insights and Forecast - By Product Type
9.1.1. Tissue Products
9.1.2. Immunosuppressive Drugs
9.1.3. Preservation Solutions
9.2. Market Analysis, Insights and Forecast - By Application
9.2.1. Organ Transplantation
9.2.2. Tissue Transplantation
9.3. Market Analysis, Insights and Forecast - By End User
9.3.1. Hospitals
9.3.2. Transplantation Centers
9.3.3. Others
9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
9.4.1. Brazil
9.4.1.1. By Application
9.4.2. Mexico
9.4.2.1. By Application
9.4.3. Rest of Latin America
9.4.3.1. By Application
10. Middle East & Africa Transplantation Market Analysis, Insights and Forecast, 2021-2034
10.1. Market Analysis, Insights and Forecast - By Product Type
10.1.1. Tissue Products
10.1.2. Immunosuppressive Drugs
10.1.3. Preservation Solutions
10.2. Market Analysis, Insights and Forecast - By Application
10.2.1. Organ Transplantation
10.2.2. Tissue Transplantation
10.3. Market Analysis, Insights and Forecast - By End User
10.3.1. Hospitals
10.3.2. Transplantation Centers
10.3.3. Others
10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
10.4.1. GCC
10.4.1.1. By Application
10.4.2. South Africa
10.4.2.1. By Application
10.4.3. Rest of Middle East & Africa
10.4.3.1. By Application
11. Competitive Analysis
11.1. Global Market Share Analysis (2025)
11.2. Company Profiles
11.2.1. Novartis AG
11.2.1.1. Overview
11.2.1.2. Products & services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Teva Pharmaceutical Industries Ltd.
11.2.2.1. Overview
11.2.2.2. Products & services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Arthrex, Inc.
11.2.3.1. Overview
11.2.3.2. Products & services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation)
